Vertex has doubled down on cell-based therapies for type 1 diabetes (T1D), buying ViaCyte in a $320 million deal that it says will accelerate development of its own candidate VX-880. The deal has ...

Making a noteworthy insider sell on November 12, ITEM SECOND IRR TRUST FBO JACOB J WESTPHAL ua of JEFFREY R WESTPHAL dated October , 10% Owner at Vertex (NASDAQ:VERX), is reported in the latest ...

Jeffrey Westphal, 10% Owner at Vertex VERX, executed a substantial insider sell on November 14, according to an SEC filing. Vertex shares are trading up 0.43% at $50.8 at the time of this writing ...

Jeffrey Westphal, 10% Owner at Vertex (NASDAQ:VERX), executed a substantial insider sell on November 14, according to an SEC filing. What Happened: Westphal's recent move involves selling ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

Mondelez International Inc. Cl A $63.84-0.65-1.01% ...

See the top gainers, losers, invest and get updated what's happening in the crypto market ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...

The UK's Top 100 biggest artist albums of the week, compiled by the Official Charts Company based on sales of CDs, downloads, vinyl, audio streams and video streams. View the biggest albums of 2024.

billboard hot 100™ the week’s most popular current songs across all genres, ranked by streaming activity data by online music sources tracked by luminate, radio airplay audience impressions as ...